Cargando…

Characterization of human DNGR-1(+) BDCA3(+) leukocytes as putative equivalents of mouse CD8α(+) dendritic cells

In mouse, a subset of dendritic cells (DCs) known as CD8α(+) DCs has emerged as an important player in the regulation of T cell responses and a promising target in vaccination strategies. However, translation into clinical protocols has been hampered by the failure to identify CD8α(+) DCs in humans....

Descripción completa

Detalles Bibliográficos
Autores principales:	Poulin, Lionel Franz, Salio, Mariolina, Griessinger, Emmanuel, Anjos-Afonso, Fernando, Craciun, Ligia, Chen, Ji-Li, Keller, Anna M., Joffre, Olivier, Zelenay, Santiago, Nye, Emma, Le Moine, Alain, Faure, Florence, Donckier, Vincent, Sancho, David, Cerundolo, Vincenzo, Bonnet, Dominique, Reis e Sousa, Caetano
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882845/ https://www.ncbi.nlm.nih.gov/pubmed/20479117 http://dx.doi.org/10.1084/jem.20092618

Ejemplares similares

Efficient and versatile manipulation of the peripheral CD4(+) T-cell compartment by antigen targeting to DNGR-1/CLEC9A
por: Joffre, Olivier P, et al.
Publicado: (2010)

Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity
por: Giampazolias, Evangelos, et al.
Publicado: (2021)

Re-evaluation of human BDCA-2(+) DC during acute sterile skin inflammation
por: Chen, Yi-Ling, et al.
Publicado: (2019)

Linking Inflammation to Natural Killer T Cell Activation
por: Salio, Mariolina, et al.
Publicado: (2009)

Regulation of Lipid Specific and Vitamin Specific Non-MHC Restricted T Cells by Antigen Presenting Cells and Their Therapeutic Potentials
por: Salio, Mariolina, et al.
Publicado: (2015)

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
por: Bedard, Melissa, et al.
Publicado: (2017)

The Immune Modulating Properties of Mucosal-Associated Invariant T Cells
por: Ioannidis, Melina, et al.
Publicado: (2020)

MR1-Restricted Mucosal-Associated Invariant T Cells and Their Activation during Infectious Diseases
por: Howson, Lauren J., et al.
Publicado: (2015)

DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells
por: Cueto, Francisco J, et al.
Publicado: (2021)

Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection
por: Ouaguia, Laurissa, et al.
Publicado: (2019)

DNGR-1, a Dendritic Cell-Specific Sensor of Tissue Damage That Dually Modulates Immunity and Inflammation
por: Cueto, Francisco J., et al.
Publicado: (2020)

Characterization of BDCA1 and BDCA4 dendritic cell subsets in rheumatoid arthritis patients
por: Lebre, MC, et al.
Publicado: (2004)

Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation
por: Veerapen, Natacha, et al.
Publicado: (2011)

Paramyxovirus Infection Regulates T Cell Responses by BDCA-1(+) and BDCA-3(+) Myeloid Dendritic Cells
por: Gupta, Meera R., et al.
Publicado: (2014)

Differential response of BDCA-1(+) and BDCA-3(+) myeloid dendritic cells to respiratory syncytial virus infection
por: Gupta, Meera R, et al.
Publicado: (2013)

DNGR-1-tracing marks an ependymal cell subset with damage-responsive neural stem cell potential
por: Frederico, Bruno, et al.
Publicado: (2022)

Myosin II Synergizes with F-Actin to Promote DNGR-1-Dependent Cross-Presentation of Dead Cell-Associated Antigens
por: Schulz, Oliver, et al.
Publicado: (2018)

CpG-matured Murine Plasmacytoid Dendritic Cells Are Capable of In Vivo Priming of Functional CD8 T Cell Responses to Endogenous but Not Exogenous Antigens
por: Salio, Mariolina, et al.
Publicado: (2004)

BDCA1(+) cDC2s, BDCA2(+) pDCs and BDCA3(+) cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients
por: Sosa Cuevas, Eleonora, et al.
Publicado: (2020)

A pH‐ and ionic strength‐dependent conformational change in the neck region regulates DNGR‐1 function in dendritic cells
por: Hanč, Pavel, et al.
Publicado: (2016)

Enterovirus-Infected β-Cells Induce Distinct Response Patterns in BDCA1(+) and BDCA3(+) Human Dendritic Cells
por: Schulte, Barbara M., et al.
Publicado: (2015)

Centriole polarisation to the immunological synapse directs secretion from cytolytic cells of both the innate and adaptive immune systems
por: Stinchcombe, Jane C, et al.
Publicado: (2011)

Elevated and cross‐responsive CD1a‐reactive T cells in bee and wasp venom allergic individuals
por: Subramaniam, Sumithra, et al.
Publicado: (2015)

Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas
por: Picco, Gianfranco, et al.
Publicado: (2014)

Invariant NKT cells modulate the suppressive activity of Serum Amyloid A-differentiated IL-10-secreting neutrophils
por: De Santo, Carmela, et al.
Publicado: (2010)

Evaluation of the BDCA2-DTR Transgenic Mouse Model in Chronic and Acute Inflammation
por: Mandl, Manuela, et al.
Publicado: (2015)

BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?
por: van Ee, Thomas J., et al.
Publicado: (2018)

Mutations in bdcA and valS Correlate with Quinolone Resistance in Wastewater Escherichia coli
por: Malekian, Negin, et al.
Publicado: (2021)

APOBEC3A Is Implicated in a Novel Class of G-to-A mRNA Editing in WT1 Transcripts
por: Niavarani, Ahmadreza, et al.
Publicado: (2015)

Escherichia coli BdcA controls biofilm dispersal in Pseudomonas aeruginosa and Rhizobium meliloti
por: Ma, Qun, et al.
Publicado: (2011)

Degradation of T Cell Receptor (TCR)–CD3-ζ Complexes after Antigenic Stimulation
por: Valitutti, Salvatore, et al.
Publicado: (1997)

TLR3 Signaling Promotes the Induction of Unique Human BDCA-3 Dendritic Cell Populations
por: Colletti, Nicholas J., et al.
Publicado: (2016)

The Effect of Chronic Hepatitis B Virus Infection on BDCA3+ Dendritic Cell Frequency and Function
por: van der Aa, Evelyn, et al.
Publicado: (2016)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases
por: Gadola, Stephan D., et al.
Publicado: (2006)

Intratumoral administration of CD1c (BDCA-1)(+) and CD141 (BDCA-3)(+) myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial
por: Schwarze, Julia Katharina, et al.
Publicado: (2022)

Frequency of Leukemic Initiating Cells does not depend on the xenotransplantation model used
por: Vargaftig, Jacques, et al.
Publicado: (2011)

Genetic profiles of plasmacytoid (BDCA-4 expressing) DC subtypes-clues to DC subtype function in vivo
por: Wrzesinski, Stephen H, et al.
Publicado: (2013)

Differential Susceptibility and Response of Primary Human Myeloid BDCA1(+) Dendritic Cells to Infection with Different Enteroviruses
por: Schulte, Barbara M., et al.
Publicado: (2013)

Accumulation of BDCA1(+) Dendritic Cells in Interstitial Fibrotic Lung Diseases and Th2-High Asthma
por: Greer, Alexandra M., et al.
Publicado: (2014)

Reducing prostaglandin E(2) production to raise cancer immunogenicity
por: Zelenay, Santiago, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s1tvum856pb4cai2na50rpqmeb